Heterogeneous p27Kip1 expression within primary renal cell cancers, their invasive margins and peritumoral renal parenchyma correlation with pathological and prognostic features

Urologia Internationalis

Volumn 79, Issue 2, 2007, Pages 164-169

  Merseburger, A S ^a   Serth, J ^b   Von Der Heyde, E ^b   Kobierski, A ^b   Wegener, U ^b   Mengel, M ^b   Jonas, U ^b   Kuczyk, M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Invasion front; p27Kip1 protein; Primary renal cell cancer; Renal cell cancer, prognosis

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CANCER; KIDNEY PARENCHYMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; SURVIVAL; TISSUE MICROARRAY; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEPHRECTOMY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN ARRAY ANALYSIS;

EID: 34548602447     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106332     Document Type: Article

References (21)

1. Vogelzang NJ, Stadler WM: Kidney cancer. Lancet 1998;352:1691-1696.
2. Gardner LB, Li Q, Park MS, et al: Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem 2001;276:7919-7926.
3. Kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 1999;154:313-323.
4. Kip1 mutation found in breast cancer. Cancer Res 1996;56:2400-2404.
5. Kip1 promoter methylation in malignant melanoma. Oncogene 2000;19:5111-5115.
6. Kip1 in prostate carcinoma. Prostate 2001;48:248-253.
7. Nakatsuka S, Liu A, Yao M, Takakuwa T, Tomita Y, Hoshida Y, Nishiu M, Aozasa K: Methylation of promoter region in p27 gene plays a role in the development of lymphoid malignancies. Int J Oncol 2003;22:561-568.
8. Bloom J, Pagano M: Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Cancer Biol 2003;13:41-47.
9. Kip1. Biochem Biophys Res Commun 2001;282:853-860.
10. Tsihlias J, Kapusta L, Slingerland J: The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu Rev Med 1999;50:401-423.
11. Haitel A, Wiener HG, Neudert B, Marberger M, Susani M: Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance. Urology 2001;58:477-481.
12. Hedberg Y, Davoodi E, Ljungberg B, Roos G, Landberg G: Cyclin E and p27 protein content in human renal cell carcinoma: clinical outcome and associations with cyclin D. Int J Cancer 2002;102:601-607.
13. Kip1 is associated with tumor size and poor prognosis in patients with renal cell carcinoma. Cancer 2002;94:973-979.
14. Kip1 expression in human renal cell cancers: implications for clinical outcome. Anticancer Res 2003;23:217-221.
15. Hedberg Y, Ljungberg B, Roos G, Landberg G: Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray. Br J Cancer 2003;88:1417-1423.
16. Mengel M, Kreipe H, von Wasielewski R: Rapid and large-scale transition of new tumor biomarkers to clinical biopsy material by innovative tissue microarray systems. Appl Immunohistochem Mol Morphol 2003;11:261-268.
17. Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer. Oncol Rep 2001;8:1401-1407.
18. Svensson S, Nilsson K, Ringberg A, Landberg G: Invade or proliferate? Two contrasting events in malignant behavior governed by p16(INK4a) and an intact Rb pathway illustrated by a model system of basal cell carcinoma. Cancer Res 2003;63:1737-1742.
19. Baldus SE, Monig SP, Huxel S, Landsberg S, Hanisch FG, Engelmann K, Schneider PM, Thiele J, Holscher AH, Dienes HP: MUC1 and nuclear β-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res 2004;10:2790-2796.
20. Palmqvist R, Rutegard JN, Bozoky B, Landberg G, Stenling R: Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters. Am J Pathol 2000;157:1947-1953.
21. Jung A, Schrauder M, Oswald U, Knoll C, Sellberg P, Palmqvist R, Niedobitek G, Btabletz T, Kirchner T: The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear β-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol 2001;159:1613-1617.